Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease
Xiao-Lu Niu1, Li Liu1, Zhi-Xiu Song1
1Department of Neurology, The First Affiliated Hospital of Xinxiang Medical University, No. 88. Jiankang Road, Weihui, Xinxiang, 453100, Henan, People's Republic of China.
Abstract:
Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities that could favor the occurrence of small intestinal bacterial overgrowth (SIBO). The aim of the study was to assess the prevalence of SIBO in Chinese patients with PD and the potential impact of SIBO on gastrointestinal symptoms and motor function. 182 consecutive Chinese patients with PD patients and 200 sex, age, and BMI-matched subjects without PD were included. All participants underwent the glucose breath test to assess SIBO. We examined the associations between factors and SIBO with logistic regression using SPSS. Fifty-five of the 182 PD patients were SIBO positive (30.2 %; 95 % CI 23.5-36.9 %) compared with 19 of 200 in the control group (9.5 %; 95 % CI 5.4-13.6 %); the difference was statistically significant (P < 0.0001; OR 4.13; 95 % CI 2.34-7.29). Motor fluctuations present was higher in the PD patients with SIBO than in the patients without SIBO (70.9 vs. 45.7 %; P = 0.002). Multivariate analysis showed that disease duration, Hoehn and Yahr stage, Unified PD Rating-III score, Unified PD Rating-IV score, and Non-Motor Symptoms Scale score were the factors associated with the SIBO-positive status in PD patients. SIBO was highly prevalent in PD, and nearly one-third was detected. SIBO was associated with worse gastrointestinal symptoms and worse motor function. Further studies are needed to specify the reasons underlying SIBO and worse motor function in PD.
Insights
Small intestinal bacterial overgrowth (SIBO) affects nearly one-third of Chinese Parkinson's disease (PD) patients. SIBO is linked to increased gastrointestinal issues and poorer motor function in those with PD.
Area of Science:
- Gastroenterology
- Neurology
- Microbiology
Background:
- Parkinson's disease (PD) is frequently accompanied by gastrointestinal dysmotility.
- This dysmotility may predispose patients to small intestinal bacterial overgrowth (SIBO).
Purpose of the Study:
- To determine the prevalence of SIBO in Chinese PD patients.
- To investigate the association between SIBO and gastrointestinal symptoms and motor function in PD.
Main Methods:
- A glucose breath test was used to diagnose SIBO.
- 182 Chinese PD patients and 200 controls were enrolled.
- Logistic regression analysis was employed to identify associated factors.
Main Results:
- SIBO prevalence was significantly higher in PD patients (30.2%) compared to controls (9.5%).
- PD patients with SIBO exhibited more frequent motor fluctuations (70.9% vs. 45.7%).
- Disease duration, Hoehn and Yahr stage, UPDRS scores, and NMSS score were associated with SIBO positivity.
Conclusions:
- SIBO is highly prevalent in Chinese PD patients.
- SIBO is associated with worsened gastrointestinal symptoms and motor function in PD.
- Further research is warranted to elucidate the causal relationship between SIBO and PD progression.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Neural Regulation
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
